EMERYVILLE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at two healthcare conferences in September.
Thomas Weisel Partners Healthcare Conference
Subsequently, Onyx will present at the Thomas Weisel Partners Healthcare Conference in Boston, Massachusetts, on September 10, 2009 at 12:55 p.m. Eastern Time.
http://www.onyx-pharm.com/view.cfm/32/Event-Calendar
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar((R)), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company’s website at www.onyxpharm.com.
SOURCE Onyx Pharmaceuticals, Inc.
CONTACT: Alex Santos of Onyx Pharmaceuticals, Inc., +1-510-597-6504
Web site: http://www.onyx-pharm.com/
